Avicanna Inc is seeing a notable rise in its stock price, reflecting positive investor sentiment.
Avicanna Inc (AVCN.TO) is up today, gaining 4.00% to close at CA$0.13. This increase comes as developments in the cannabis sector continue to attract investor interest.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Avicanna Inc
AVCN.TO
AVCN.TO
Avicanna Inc
WealthAwesomeMarket cap
$16.35M
52W high
$0.30
52W low
$0.10
1W change
-7.41%
Beta
0.33
Analyst Price Targets
Based on analyst covering AVCN
Wall Street analysts forecast AVCN stock price to rise 460.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.70
+460.0% Upside
Current Price
C$0.13
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCN's historical volatility
30-Day Vol
70.4%
Annualized
90-Day Vol
67.1%
Annualized
Trend (90d)
-47.6%
Annualized drift
90d Mean
C$0.11
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.12 | C$0.09 – C$0.15 |
| 60 trading days | C$0.11 | C$0.08 – C$0.16 |
| 90 trading days | C$0.11 | C$0.07 – C$0.16 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: This price increase may signal growing confidence in Avicanna's future, especially as the company expands its product offerings.
4.00% Increase in Stock Price
Avicanna's stock price increase corresponds to a market cap of CA$15,723,984, showing a rising interest in the company's potential.
Bull case
The recent launch of Avicanna's QUIX™ Rapid-Onset Medical Cannabis Portfolio could drive future revenue growth. This product appeals to a market that increasingly values quick-acting medical solutions, positioning Avicanna well for success.
Bear case
Despite today's gains, Avicanna faces challenges like a negative profit margin and the typical volatility of the cannabis sector, which could affect long-term performance.
Market Performance Overview
Advertisement
Avicanna Inc's stock is up today, reflecting a positive shift in market sentiment. The stock has gained 4.00%, bringing its price to CA$0.13. This performance may indicate growing investor confidence as the company continues to innovate and expand its product lines.
Recent Developments
Avicanna's recent product launches, especially the QUIX™ Rapid-Onset Medical Cannabis Portfolio, likely contribute to today's stock performance. New products can enhance the company's market position and attract a broader customer base, potentially driving future growth.
Investor Considerations
While today's gains are encouraging, investors should stay cautious. Avicanna's negative profit margin shows ongoing challenges, and the volatility of the cannabis market can lead to unpredictable stock movements. It's important to weigh these factors against the potential for future growth.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
